Tredegar (TG) Q4 2024 earnings summary

Executive summary

• Fourth quarter 2024 net loss from continuing operations was $7.3M, a significant improvement from $34.1M loss in Q4 2023; ongoing operations net income was $2.0M, up from $1.1M in Q4 2023.

• Full year 2024 net income from continuing operations was $1.0M, compared to a $99.2M loss in 2023; ongoing operations net income was $17.2M, up from a $2.0M loss in 2023.

• Sale of Terphane completed in Q4 2024, with $9.8M additional proceeds received in Q1 2025.

Financial highlights

• 2024 sales were $598M, up from $573M in 2023.

• Net debt reduced to $54.8M at year-end 2024 from $113.2M at year-end 2023.

• Net leverage ratio improved to 1.1x from 3.7x year-over-year.

• Consolidated EBITDA from ongoing operations was $50.5M in 2024, up from $30.3M in 2023.

• Interest expense decreased to $4.7M in 2024 from $6.3M in 2023.

Outlook and guidance

• Projected 2025 capital expenditures: $17M for Aluminum Extrusions, $3M for PE Films.

• Depreciation and amortization expected at $16M and $2M for Aluminum Extrusions, $5M for PE Films in 2025.

• Management supports increased tariffs on aluminum imports, expecting positive impact on U.S. extruders.